Table 1. Correlation between immunohistochemical variables and clinicopathologic features of ICC patients in the cohort (n = 322).
Characteristics | CD68+ TAMs | CD86+ TAMs | CD206+ TAMs | ||||||
---|---|---|---|---|---|---|---|---|---|
Low | High | P# | Low | High | P# | Low | High | P# | |
Age, years | |||||||||
≤51 | 88 | 81 | 0.503 | 87 | 82 | 0.655 | 79 | 90 | 0.264 |
>51 | 73 | 80 | 74 | 79 | 82 | 71 | |||
Gender | |||||||||
Female | 69 | 59 | 0.305 | 57 | 71 | 0.139 | 71 | 57 | 0.139 |
Male | 92 | 102 | 104 | 90 | 90 | 104 | |||
Hepatitis history | |||||||||
No | 104 | 94 | 0.303 | 94 | 104 | 0.303 | 100 | 98 | 0.909 |
Yes | 57 | 67 | 67 | 57 | 61 | 63 | |||
CA199 (U/ml) | |||||||||
≤36 | 85 | 72 | 0.181 | 67 | 90 | 0.014 | 86 | 71 | 0.118 |
>36 | 76 | 89 | 94 | 71 | 75 | 90 | |||
Lymph node metastasis | |||||||||
No | 135 | 131 | 0.659 | 124 | 142 | 0.012 | 143 | 123 | 0.005 |
Yes | 26 | 30 | 37 | 19 | 18 | 38 | |||
Liver cirrhosis | |||||||||
No | 121 | 115 | 0.529 | 107 | 129 | 0.008 | 126 | 110 | 0.058 |
Yes | 40 | 46 | 54 | 32 | 35 | 51 | |||
Tumor size (cm) | |||||||||
≤5 | 75 | 70 | 0.654 | 75 | 70 | 0.654 | 80 | 65 | 0.117 |
>5 | 86 | 91 | 86 | 91 | 81 | 96 | |||
Tumor number | |||||||||
Single | 121 | 123 | 0.897 | 120 | 124 | 0.697 | 123 | 121 | 0.897 |
Multiple | 40 | 38 | 41 | 37 | 38 | 40 | |||
Vascular invasion | |||||||||
No | 135 | 141 | 0.426 | 133 | 143 | 0.151 | 145 | 131 | 0.038 |
Yes | 26 | 20 | 28 | 18 | 16 | 30 | |||
Tumor encapsulation | |||||||||
None | 146 | 137 | 0.171 | 145 | 138 | 0.305 | 141 | 142 | 1.000 |
Complete | 15 | 24 | 16 | 23 | 20 | 19 | |||
Tumor differentiation | |||||||||
I–II | 127 | 122 | 0.595 | 122 | 127 | 0.595 | 127 | 122 | 0.595 |
III | 34 | 39 | 39 | 34 | 34 | 39 | |||
TNM stage | |||||||||
I + II | 129 | 119 | 0.233 | 116 | 132 | 0.046 | 137 | 111 | 0.001 |
III + IV | 32 | 42 | 45 | 29 | 24 | 50 |
Notes:
ICC, intrahepatic cholangiocarcinoma; TNM, tumor-node-metastasis.
Bold values indicate P < 0.05.
The Pearson Chi square test was applied.